China Approves Sinopharm's Covid-19 Vaccine as it Moves to Inoculate Millions

Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials. But crucial questions remained unanswered. https://www.nytimes.com